Showing results (61-70 of 531) with videos related to
Sort By:
Pageof 54
Current Opinion in Infectious Diseases|September 12, 2014
What's new in the treatment of serious MRSA infection?Natasha E Holmes, Benjamin P HowdenThe Journal of Antimicrobial Chemotherapy|December 6, 2018
Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307Kelly L Wyres, Jane Hawkey, Marit A K Hetland, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureusBenjamin P Howden, M Lindsay GraysonExpert Opinion on Emerging Drugs|March 16, 2007
Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directionsEmma J Bishop, Benjamin P HowdenNature Reviews. Microbiology|December 17, 2008
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulceransCaroline Demangel, Timothy P Stinear, Stewart T ColeMbio|August 15, 2013
Genomic insights to control the emergence of vancomycin-resistant enterococciBenjamin P Howden, Kathryn E Holt, Margaret M C Lam, et al.Msphere|February 7, 2018
Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant <i>Staphylococcus aureus</i>Romain Guérillot, Anders Gonçalves da Silva, Ian Monk, et al.The Journal of Antimicrobial Chemotherapy|August 18, 2016
Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faeciumGlen P Carter, Andrew H Buultjens, Susan A Ballard, et al.Microbiology Spectrum|June 25, 2024
A <i>Mycobacterium ulcerans</i> vaccine pilot trial using an accurate low-dose challengeStephen Muhi, Jessica L Porter, Timothy P StinearCommunicable Diseases Intelligence Quarterly Report|November 14, 2014
Australian Enterococcal Sepsis Outcome Progamme, 2011Geoffrey W Coombs, Julie C Pearson, Tam Le, et al.Pageof 54